Form 8-K - Current report:
SEC Accession No. 0001558370-24-013161
Filing Date
2024-10-07
Accepted
2024-10-07 07:00:29
Documents
44
Period of Report
2024-10-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nrbo-20241007x8k.htm   iXBRL 8-K 47610
2 EX-99.1 nrbo-20241007xex99d1.htm EX-99.1 52939
3 GRAPHIC nrbo-20241007x8k001.jpg GRAPHIC 12152
4 GRAPHIC nrbo-20241007xex99d1g001.jpg GRAPHIC 125468
5 GRAPHIC nrbo-20241007xex99d1g002.jpg GRAPHIC 200328
6 GRAPHIC nrbo-20241007xex99d1g003.jpg GRAPHIC 166278
7 GRAPHIC nrbo-20241007xex99d1g004.jpg GRAPHIC 134655
8 GRAPHIC nrbo-20241007xex99d1g005.jpg GRAPHIC 60505
9 GRAPHIC nrbo-20241007xex99d1g006.jpg GRAPHIC 126703
10 GRAPHIC nrbo-20241007xex99d1g007.jpg GRAPHIC 116514
11 GRAPHIC nrbo-20241007xex99d1g008.jpg GRAPHIC 175125
12 GRAPHIC nrbo-20241007xex99d1g009.jpg GRAPHIC 188838
13 GRAPHIC nrbo-20241007xex99d1g010.jpg GRAPHIC 135450
14 GRAPHIC nrbo-20241007xex99d1g011.jpg GRAPHIC 170177
15 GRAPHIC nrbo-20241007xex99d1g012.jpg GRAPHIC 190541
16 GRAPHIC nrbo-20241007xex99d1g013.jpg GRAPHIC 243304
17 GRAPHIC nrbo-20241007xex99d1g014.jpg GRAPHIC 194793
18 GRAPHIC nrbo-20241007xex99d1g015.jpg GRAPHIC 118781
19 GRAPHIC nrbo-20241007xex99d1g016.jpg GRAPHIC 103704
20 GRAPHIC nrbo-20241007xex99d1g017.jpg GRAPHIC 177249
21 GRAPHIC nrbo-20241007xex99d1g018.jpg GRAPHIC 120027
22 GRAPHIC nrbo-20241007xex99d1g019.jpg GRAPHIC 131609
23 GRAPHIC nrbo-20241007xex99d1g020.jpg GRAPHIC 145862
24 GRAPHIC nrbo-20241007xex99d1g021.jpg GRAPHIC 141887
25 GRAPHIC nrbo-20241007xex99d1g022.jpg GRAPHIC 151380
26 GRAPHIC nrbo-20241007xex99d1g023.jpg GRAPHIC 113095
27 GRAPHIC nrbo-20241007xex99d1g024.jpg GRAPHIC 126565
28 GRAPHIC nrbo-20241007xex99d1g025.jpg GRAPHIC 126941
29 GRAPHIC nrbo-20241007xex99d1g026.jpg GRAPHIC 103813
30 GRAPHIC nrbo-20241007xex99d1g027.jpg GRAPHIC 108817
31 GRAPHIC nrbo-20241007xex99d1g028.jpg GRAPHIC 134868
32 GRAPHIC nrbo-20241007xex99d1g029.jpg GRAPHIC 131076
  Complete submission text file 0001558370-24-013161.txt   5938406

Data Files

Seq Description Document Type Size
33 EX-101.SCH nrbo-20241007.xsd EX-101.SCH 3148
34 EX-101.LAB nrbo-20241007_lab.xml EX-101.LAB 15928
35 EX-101.PRE nrbo-20241007_pre.xml EX-101.PRE 10071
46 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20241007x8k_htm.xml XML 4871
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 241356137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)